Larimar Therapeutics, Inc.LRMRNASDAQ

Revenue (LTM)

Net Income (LTM)

$-166M

-105.5% YoY

Free Cash Flow

$-113M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-50	-37↑27.6%	-42↓14.3%	-91↓117.7%	-172↓89.8%
Net Income	-51	-35↑30.2%	-37↓4.5%	-81↓118.1%	-166↓105.5%
EBITDA	-50	-36↑27.8%	-41↓14.5%	-91↓118.5%	-172↓90.5%
EPS Diluted	-2.93	-1.33↑54.6%	-0.84↑36.8%	-1.32↓57.1%	0.00

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	70	27↓61.7%	27↓0.3%	33↑24.2%	85↑157.1%
Total Current Assets	72	121↑67.2%	90↓25.3%	195↑116.6%	142↓27.3%
Total Assets	79	126↑60.7%	96↓24.1%	200↑108.7%	146↓27.2%
Total Current Liabilities	9	11↑21.0%	10↓11.2%	24↑156.2%	65↑166.0%
Total Liabilities	14	16↑8.8%	14↓8.3%	28↑99.9%	68↑138.5%
Total Equity	64	111↑72.2%	82↓26.3%	172↑110.2%	78↓54.6%
Total Debt	6	5↓9.9%	6↑2.6%	5↓7.7%	4↓20.5%
Net Debt	-64	-21↑66.6%	-21↑1.0%	-28↓32.5%	-81↓189.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-42	-28↑34.5%	-33↓21.4%	-71↓111.5%	-113↓60.0%
Capital Expenditure	-0	-0↑70.0%	-0↓64.0%	-1↓214.0%	-0↑82.3%
Free Cash Flow	-42	-28↑34.8%	-34↓21.5%	-71↓112.0%	-113↓59.0%
Stock-Based Comp	5	7↑20.9%	0	9	7↓20.4%
Net Change in Cash	2	-43↓2320.2%	-0↑99.8%	6↑7647.4%	52↑809.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance